Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1540452/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841561172743028736 |
|---|---|
| author | Barry J. Byrne Giancarlo Parenti Giancarlo Parenti Benedikt Schoser Ans T. van der Ploeg Hung Do Brian Fox Mitchell Goldman Franklin K. Johnson Jia Kang Nickita Mehta John Mondick M. Osman Sheikh Sheela Sitaraman Das Steven Tuske Jon Brudvig Jill M. Weimer Tahseen Mozaffar |
| author_facet | Barry J. Byrne Giancarlo Parenti Giancarlo Parenti Benedikt Schoser Ans T. van der Ploeg Hung Do Brian Fox Mitchell Goldman Franklin K. Johnson Jia Kang Nickita Mehta John Mondick M. Osman Sheikh Sheela Sitaraman Das Steven Tuske Jon Brudvig Jill M. Weimer Tahseen Mozaffar |
| author_sort | Barry J. Byrne |
| collection | DOAJ |
| format | Article |
| id | doaj-art-3600628dfa994bfab01c6f18d64330fe |
| institution | Kabale University |
| issn | 1664-2295 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neurology |
| spelling | doaj-art-3600628dfa994bfab01c6f18d64330fe2025-01-03T05:10:18ZengFrontiers Media S.A.Frontiers in Neurology1664-22952025-01-011510.3389/fneur.2024.15404521540452Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe diseaseBarry J. Byrne0Giancarlo Parenti1Giancarlo Parenti2Benedikt Schoser3Ans T. van der Ploeg4Hung Do5Brian Fox6Mitchell Goldman7Franklin K. Johnson8Jia Kang9Nickita Mehta10John Mondick11M. Osman Sheikh12Sheela Sitaraman Das13Steven Tuske14Jon Brudvig15Jill M. Weimer16Tahseen Mozaffar17Department of Pediatrics in the College of Medicine, University of Florida, Gainesville, FL, United StatesMetabolic Unit, Department of Translational Medical Sciences, University of Naples Federico II, Naples, ItalyTelethon Institute of Genetics and Medicine, Pozzuoli, ItalyFriedrich-Baur-Institute, Department of Neurology, LMU University Hospital, LMU Munich, Munich, GermanyErasmus MC University Medical Center, Rotterdam, NetherlandsM6P-Therapeutics, St Louis, MO, United StatesAmicus Therapeutics, Inc., Princeton, NJ, United StatesAmicus Therapeutics, Inc., Princeton, NJ, United StatesAmicus Therapeutics, Inc., Princeton, NJ, United StatesMetrum Research Group, Tariffville, CT, United StatesAmicus Therapeutics, Inc., Princeton, NJ, United StatesIncyte Corporation, Wilmington, DE, United StatesAmicus Therapeutics, Inc., Princeton, NJ, United StatesAmicus Therapeutics, Inc., Princeton, NJ, United StatesAmicus Therapeutics, Inc., Princeton, NJ, United StatesAmicus Therapeutics, Inc., Princeton, NJ, United StatesAmicus Therapeutics, Inc., Princeton, NJ, United States0Department of Neurology, University of California, Irvine, Irvine, CA, United Stateshttps://www.frontiersin.org/articles/10.3389/fneur.2024.1540452/fullPompe diseaseglycogen storage disease type IIlysosomal storage disordersenzyme replacement therapyn-butyldeoxynojirimycin |
| spellingShingle | Barry J. Byrne Giancarlo Parenti Giancarlo Parenti Benedikt Schoser Ans T. van der Ploeg Hung Do Brian Fox Mitchell Goldman Franklin K. Johnson Jia Kang Nickita Mehta John Mondick M. Osman Sheikh Sheela Sitaraman Das Steven Tuske Jon Brudvig Jill M. Weimer Tahseen Mozaffar Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease Frontiers in Neurology Pompe disease glycogen storage disease type II lysosomal storage disorders enzyme replacement therapy n-butyldeoxynojirimycin |
| title | Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease |
| title_full | Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease |
| title_fullStr | Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease |
| title_full_unstemmed | Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease |
| title_short | Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease |
| title_sort | corrigendum cipaglucosidase alfa plus miglustat linking mechanism of action to clinical outcomes in late onset pompe disease |
| topic | Pompe disease glycogen storage disease type II lysosomal storage disorders enzyme replacement therapy n-butyldeoxynojirimycin |
| url | https://www.frontiersin.org/articles/10.3389/fneur.2024.1540452/full |
| work_keys_str_mv | AT barryjbyrne corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT giancarloparenti corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT giancarloparenti corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT benediktschoser corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT anstvanderploeg corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT hungdo corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT brianfox corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT mitchellgoldman corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT franklinkjohnson corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT jiakang corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT nickitamehta corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT johnmondick corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT mosmansheikh corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT sheelasitaramandas corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT steventuske corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT jonbrudvig corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT jillmweimer corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease AT tahseenmozaffar corrigendumcipaglucosidasealfaplusmiglustatlinkingmechanismofactiontoclinicaloutcomesinlateonsetpompedisease |